ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,268.65
0.26%
Dow Jones
38,807.33
0.25%
Gold vs US Dollar
2,361.50
0.27%
Brent Oil
78.88
0.41%
Bitcoin
70,908.16
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) News

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TERN
DateTimeSourceHeadlineSymbolCompany
03/06/202421:10GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
30/05/202413:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
17/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202421:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202413:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
13/05/202413:05GlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
08/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
07/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024NASDAQ:TERNTerns Pharmaceuticals Inc
03/05/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
29/04/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive DifferentiationNASDAQ:TERNTerns Pharmaceuticals Inc
10/04/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/03/202420:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
11/03/202420:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
07/03/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
05/03/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
27/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
15/02/202423:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
14/02/202413:57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
07/02/202413:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
02/02/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
26/01/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
04/01/202421:05GlobeNewswire Inc.Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
03/01/202421:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
29/11/202321:05GlobeNewswire Inc.Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:TERNTerns Pharmaceuticals Inc
27/11/202321:05GlobeNewswire Inc.Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
14/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
13/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023NASDAQ:TERNTerns Pharmaceuticals Inc
09/11/202313:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Your Recent History

BOV
CXSE3F
Caixa Seguridade Partici... ON
NYSE
PRM
Perimeter Solutions
COIN
CFXKRW
Conflux
TSXV
NGG
BIT
P1U068
NLBNPIT1U068 20240621 7.5
BIT
UI980C
Unicredit Bank
NASDAQ
FIUBOX
Balanced Income Equity a...
TG
SR6
Soup
TSXV
CCCM
C3 Metals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved